All Stories

  1. Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses
  2. Unraveling the Genome Diversity of Leishmania Parasites Using Next-Generation DNA Sequencing Strategies
  3. Advances in Leishmania Vaccines: Current Development and Future Prospects
  4. Lethality associated with snake venom exposure can be predicted by temperature drop in Swiss mice
  5. Correction: De Jesus et al. Body Temperature Drop as a Humane Endpoint in Snake Venom-Lethality Neutralization Tests. Toxins 2023, 15, 525
  6. Body Temperature Drop as a Humane Endpoint in Snake Venom-Lethality Neutralization Tests
  7. Comparison of Cost and Potency of Human Mesenchymal Stromal Cell Conditioned Medium Derived from 2- and 3-Dimensional Cultures
  8. Development of <em>Leishmania</em> Species Strains with Constitutive Expression of eGFP
  9. One Health Approach to Identify Research Needs on Rhipicephalus microplus Ticks in the Americas
  10. Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama
  11. Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama
  12. HLA allele and haplotype frequencies in the Panamanian population
  13. Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection
  14. Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
  15. <em>Betacoronavirus</em> Genomes: How Genomic Information Has Been Used to Deal with past Outbreaks and the COVID-19 Pandemic
  16. Environmental Conditions May Shape the Patterns of Genomic Variations in Leishmania panamensis
  17. Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer’s Disease
  18. Use of AFLP for the study of eukaryotic pathogens affecting humans
  19. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2
  20. VianniaTopes: a database of predicted immunogenic peptides forLeishmania(Viannia) species
  21. Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer’s Disease
  22. Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2
  23. Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles
  24. Genome-wide discovery and development of polymorphic microsatellites from Leishmania panamensis parasites circulating in central Panama
  25. The genome of Leishmania panamensis: insights into genomics of the L. (Viannia) subgenus.
  26. Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
  27. A Pseudopterane Diterpene Isolated From the Octocoral Pseudopterogorgia acerosa Inhibits the Inflammatory Response Mediated by TLR-Ligands and TNF-Alpha in Macrophages
  28. AFLP Polymorphisms Allow High Resolution Genetic Analysis of American Tegumentary Leishmaniasis Agents Circulating in Panama and Other Members of the Leishmania Genus
  29. Two initial vaccinations with the Bm86-based Gavacplus vaccine against Rhipicephalus (Boophilus) microplusinduce similar reproductive suppression to three initial vaccinations under production conditions
  30. Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: Advantages for immunization strategies and vaccine implementation
  31. Molecular and antigenic characterization of rabbit hemorrhagic disease virus isolated in Cuba indicates a distinct antigenic subtype
  32. The recombinant rabbit hemorrhagic disease virus VP60 protein obtained from Pichia pastoris induces a strong humoral and cell-mediated immune response following intranasal immunization in mice
  33. High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris
  34. Genetic structure of a Cuban population based on nine short tandem repeat loci
  35. Production and biochemical characterization of the recombinant Boophilus microplus Bm95 antigen from Pichia pastoris
  36. Genetic structure of the contemporary Cuban population for nine STR loci
  37. Forensic identification of skeletal remains from members of Ernesto Che Guevara’s guerrillas in Bolivia based on DNA typing
  38. Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac™
  39. Field studies and cost-effectiveness analysis of vaccination with Gavac? against the cattle tick Boophilus microplus*1
  40. Simulation of control strategies for the cattle tick Boophilus microplus employing vaccination with a recombinant Bm86 antigen preparation
  41. Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice
  42. Differential constitutive expression of interferon genes in early mouse embryos
  43. Transgenic rabbits as bioreactors for the production of human growth hormone
  44. Control of Boophilus microplus populations in grazing cattle vaccinated with a recombinant Bm86 antigen preparation
  45. Transient transformation of shrimp (Penaeus schmitti) embryos by DNA microinjection
  46. Detection of Bm86 antigen in different strains of Boophilus microplus and effectiveness of immunization with recombinant Bm86
  47. High level expression of the B. microplus Bm86 antigen in the yeast Pichia pastoris forming highly immunogenic particles for cattle
  48. Molecular cloning of the gene, expression in E. coli and purification of the thermus aquaticus DNA polymerase I
  49. A Novel, Quantitative Bioassay for Type I Interferon Using a Recombinant Indicator Cell Line